PepGen Inc.
PepGen Inc. (PEPG): 4 pipeline candidates · ~21 mo cash runway · 5 clinical trials. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
20.9 months
D/E 0.17
Lead: Phase 2
4 candidates
N/A
0 buys · 7 sells (180d)
A transparent, data-derived signal for PepGen Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$105.8M
Cash
$42.1M
Quarterly Burn
$18.4M
Runway
20.9 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (4 candidates)
| Drug | Phase |
|---|---|
| iv infusion | Phase 2 |
| pgn-edo51 | Phase 2 |
| pgn-edodm1 | Phase 2 |
| pgn-edodm1 for infusion | Phase 2 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
92
Total value held
$95.9M
| Holder | Shares | Value |
|---|---|---|
| ra capital management, l.p. | 20,064,545 | $35.5M |
| commodore capital lp | 4,475,000 | $7.9M |
| vanguard capital management llc | 3,875,398 | $6.9M |
| viking global investors lp | 3,482,434 | $6.2M |
| laurion capital management lp | 2,750,855 | $4.9M |
| millennium management llc | 2,079,143 | $3.7M |
| kalehua capital management llc | 1,729,961 | $3.1M |
| adar1 capital management, llc | 1,607,638 | $2.8M |
| pictet asset management holding sa | 1,306,783 | $2.3M |
| blackrock, inc. | 1,277,784 | $2.3M |
Showing top 10 of 92 institutional holders of PepGen Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in PepGen Inc.'s pipeline?
PepGen Inc. (PEPG) has 4 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is PepGen Inc.'s lead drug candidate?
PepGen Inc.'s most advanced tracked candidate is iv infusion (Phase 2) for Duchenne Muscular Dystrophy (DMD).
What is PepGen Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, PepGen Inc. has approximately 20.9 months of cash runway.
What is PepGen Inc.'s market capitalization?
PepGen Inc.'s market capitalization is approximately $105.8M.
Who is the CEO of PepGen Inc.?
Dr. James G. McArthur Ph.D. is the chief executive officer of PepGen Inc. (PEPG).
Get the full picture on PepGen Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.